Public procurement notice: Voluntary Ex Ante Transparency Notice
Published: 2022-12-19
Buyer: SYKEHUSINNKJØP HF
Country: NO
Contract type: Supplies
Procedure: Contract award without prior publication
CPV classification: 33000000 | 33696500 | 38000000
Estimated value: 4800000 NOK
Award criteria: The most economic tender

Technical requirements: Lääketieteelliset laitteet, farmaseuttiset valmisteet ja henkilökohtaiseen hygieniaan liittyvät tuotteet
Bergen Hospital Trust intends to enter into amendment contracts with HD Medical AS (previously Medical Wire & Equipment) and Roche Diagnostics Norge AS (Roche) for reagents for examining bowel pathogenic microbes. The amendment concerns an extension to the contracts until 31.03.2024. HD Medical currently has a contract with Bergen Hospital Trust for the delivery of analyses for detecting bowel pathogenic viruses and parasites, and an equivalent with Roche for detecting bacteria.
Bergen Hospital Trust will make a new procurement that will require IVDR-certified reagents. There are two reasons why we would like to postpone the start-up of the new procurement:
- The market is still not ready for IVDR-certified panels. We know that there are several suppliers that will soon be able to offer IVDR-certified panels.
- There is a need for resources for new instruments for the introduction of IVDR-certified panels now.
Bergen Hospital Trust regards the market as not yet ready for IVDR-certified panels, and we are aware that more tenderers will be ready in the future. At the same time resources are required for new instruments in order to implement the IVDR-certified analyses, in a period of great economic uncertainty. This has led to the conclusion that it is most appropriate to postpone the start-up of a new procurement process. According to the schedule, Bergen Hospital Trust will announce a new procurement of PCR analyses for bowel pathogenic microbes in 2023, and have the analyses fully implemented and ready for sue in Q1 2024. Please note that this a tentative schedule.
Furthermore, it is not appropriate to procure new temporary contracts for panels that are not IVDR-certified. There are several suppliers that can deliver these, but it will be disproportionally demanding to hold a contest when it is only for a short period. The procurement would take time, particularly as regards the necessary evaluation. It is therefore not appropriate to hold a contest for a temporary contract for reagents that will regardless be replaced with IVDR-certified variants after a short time.
Based on the mentioned justifications, the contracting authority believes that there is a legal basis to enter into a contract with Roche and HD Medical without announcing a contest, cf. the Public Procurement Regulations, Section 13-4 first paragraph letter c.
Bergen Hospital Trust intends to enter into amendment contracts with HD Medical AS (previously Medical Wire & Equipment) and Roche Diagnostics Norge AS (Roche) for reagents for examining bowel pathogenic microbes. The amendment concerns an extension to the contracts until 31.03.2024. HD Medical currently has a contract with Bergen Hospital Trust for the delivery of analyses for detecting bowel pathogenic viruses and parasites, and an equivalent with Roche for detecting bacteria.
Bergen Hospital Trust will make a new procurement that will require IVDR-certified reagents. There are two reasons why we would like to postpone the start-up of the new procurement:
- The market is still not ready for IVDR-certified panels. We know that there are several suppliers that will soon be able to offer IVDR-certified panels.
- There is a need for resources for new instruments for the introduction of IVDR-certified panels now.
Bergen Hospital Trust regards the market as not yet ready for IVDR-certified panels, and we are aware that more tenderers will be ready in the future. At the same time resources are required for new instruments in order to implement the IVDR-certified analyses, in a period of great economic uncertainty. This has led to the conclusion that it is most appropriate to postpone the start-up of a new procurement process. According to the schedule, Bergen Hospital Trust will announce a new procurement of PCR analyses for bowel pathogenic microbes in 2023, and have the analyses fully implemented and ready for sue in Q1 2024. Please note that this a tentative schedule.
Furthermore, it is not appropriate to procure new temporary contracts for panels that are not IVDR-certified. There are several suppliers that can deliver these, but it will be disproportionally demanding to hold a contest when it is only for a short period. The procurement would take time, particularly as regards the necessary evaluation. It is therefore not appropriate to hold a contest for a temporary contract for reagents that will regardless be replaced with IVDR-certified variants after a short time.


Winner: HD Medical AS
Award value: 4800000